Trace elements in human physiology and pathology. Copper

Biomedicine and Pharmacotherapy

Volumn 57, Issue 9, 2003, Pages 386-398

  Tapiero, H ^a   Townsend, D M ^b   Tew, K D ^b  

^a UNIV PARIS SUD   (France)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

Bioavailability; Ceruloplasmin; Copper; Deficiency; Enzymes; Metallothionein

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALBUMIN; ALPHA AMIDATING ENZYME; AMINE; AMINE OXIDASE (FLAVIN CONTAINING); AMINO ACID DERIVATIVE; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; CARRIER PROTEIN; CERULOPLASMIN; CERULOPLASMIN II; CHAPERONE; COPPER ION; COPPER ZINC SUPEROXIDE DISMUTASE; DOPAMINE BETA MONOOXYGENASE; ELASTIN; FREE RADICAL; GLUTATHIONE; IRON; METALLOTHIONEIN; MONOPHENOL MONOOXYGENASE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; OXIDOREDUCTASE; PEPTIDE DERIVATIVE; PROTEIN; PROTEIN DERIVATIVE; PROTEIN LYSINE 6 OXIDASE; SCAVENGER; TRACE ELEMENT; TRANSCUPREIN; UNCLASSIFIED DRUG;

ABSORPTION; ACERULOPLASMINEMIA; ALZHEIMER DISEASE; ANEMIA; CANCER; CATALYSIS; CATALYST; CELL FUNCTION; CELL SECRETION; CELL TRANSPORT; CROSS LINKING; CYTOPLASM; DETOXIFICATION; DIETARY INTAKE; ELECTRON TRANSPORT; EMBRYO DEVELOPMENT; ENZYME MECHANISM; ENZYME METABOLISM; GENE MUTATION; HOMEOSTASIS; HUMAN; INFECTION; INFLAMMATION; ION CURRENT; ION TRANSPORT; IRON ABSORPTION; IRON STORAGE; MENKES SYNDROME; METAL BINDING; MITOCHONDRIAL RESPIRATION; MOLECULAR DYNAMICS; NONHUMAN; OXIDATION REDUCTION REACTION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVIEW; WILSON DISEASE;

EID: 0344688221     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(03)00012-X     Document Type: Review

References (204)

1. Linder M.C. Biochemistry of copper. 1991;Plenum Press, New York.
2. Walker W.R. The results of a copper bracelet clinical trial and subsequent studies. Sorenson Jr J. Inflammatory diseases and copper. 1982;469-478 Humana, Totowa (NJ).
3. 65Cu. Am J Clin Nutr. 49:1989;870-878.
4. Scott K.C., Turnlund J.R. Compartment model of copper metabolism in adult men. J Nutr Biochem. 5:1994;342-350.
5. Linder M.C., Hazegh-Azam M. Copper biochemistry and molecular biology. Am J Clin Nutr. 63:1996;797S-811S.
6. 65Cu. Am J Clin Nutr. 67:1998;1219S-1225S.
7. Halliwell B., Gutteridge J.M. Oxygen toxicity, oxygen radicals, transition metals and diseases. Biochem J. 219:1984;1-4.
8. Halliwell B., Gutteridge J.M. Role of free radicals and catalytic metal ions in human disease: an overview. Meth Enzymol. 186:1990;1-85.
9. Predki P.F., Sarkar B. Effect of replacement of "zinc finger" zinc on estrogen receptor DNA interactions. J Biol Chem. 267:1992;5842-5846.
10. Bull P.C., Cox D.W. Wilson disease and Menkes disease: new handles on heavy-metal transport. Trends Genet. 10:1994;246-252.
11. Bull P.C., Thomas G.R., Rommens J.M., Forbe J.R., Cox D.W. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet. 5:1993;327-337.
12. Chelly J., Tumer Z., Tonnesen T., Petterson A., Ishikawa-Brush Y., Tommerup N., et al. Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat Genet. 3:1993;14-19.
13. Mercer J.F.B., Livingston J., Hall B., Paynter J.A., Begy C., Chandrasekharappa S., et al. Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat Genet. 3:1993;20-25.
14. Yamaguchi Y., Heiny M.E., Gitlin J.D. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun. 197:1993;271-277.
15. Vulpe C.D., Kuo Y.M., Murphy T.L., Cowley L., Askwith C., Libina N., et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet. 21:1999;195-199.
16. Cohen N.L., Illowsky B., Linder M.C. Altered Copper absorption in tumor bearing and estrogen treated rats. Am J Physiol. 236:1979;E309-315.
17. Freedman J.H., Ciriolo M.R., Peisach J. The role of glutathione in copper metabolism and toxicity. J Biol Chem. 264:1989;5598-5605.
18. Steinebach O.M., Wolterbeek H.T. Role of cytosolic copper, metallothionein and glutathione in copper toxicity in rat hepatoma tissue culture cells. Toxicology. 92:1994;75-90.
19. Keogh J.P., Steffen B., Siegers C.P. Cytotoxicity of heavy metals in the human small intestinal epithelial, cell line I-407: the role of glutathione. J Toxicol Environ Health. 43:1994;351-359.
20. Stillman M.J., Shaw C.F. III, Suzuki K.T. Metallothioneins. Synthesis, structure and properties of metallothioneins, phytochelatins and metal-thiolate complexes. 1992;55-127 VCH, New York.
21. Culotta V.C., Hamer D.H. Fine mapping of a mouse metallothionein gene metal response element. Mol Cell Biol. 9:1989;1376-1380.
22. Masters B.A., Ouaife C.J., Ericksen J.C., Kelly E.J., Froelick G.J., Zambrowicz B.P., et al. Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles. J Neurosci. 14:1994;5844-5857.
23. Masters B.A., Kelly E.J., Ouaife C.J., Brinster R.L., Palmiter R.D. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc Natl Acad Sci USA. 91:1994;584-588.
24. McArdle H.J., Mercer J.F., Sargeson A.M., Danks D.M. Effects of cellular copper content on copper uptake and metallothionein and ceruloplasmin mRNA levels in mouse hepatocytes. J Nutr. 120:1990;1370-1375.
25. Westin G., Schaffner W. A zinc-responsive factor interacts with a metal-regulated enhancer element (MRE) of the mouse metallothionein-1 gene. EMBO J. 7:1988;3763-3770.
26. Furst P., Hu S., Hackett R., Hamer D. Copper activates metallothionein gene transcription by altering the conformation of a specific DNA binding protein. Cell. 55:1988;705-717.
27. Furst P., Hamer D. Cooperative activation of a eukaryotic transcription factor: interaction between Cu(I) and yeast ACEI protein. Proc Natl Acad Sci USA. 86:1989;5267-5271.
28. Butler G., Thiele D.J. ACE2, an activator of yeast metallothionein expression which is homologous to SWI5. Mol Cell Biol. II:1991;476-485.
29. Thiele D.J., Hamer D.H. Tandemly duplicated upstream control sequences mediate copper-induced transcription of the Saccharomyces cerevisiae copper-metallothionein gene. Mol Cell Biol. 6:1986;1158-1163.
30. Culotta V.C., Howard W.R., Liu X.F. CRS5 encodes a metallothionein-like protein in Saccharomyces cerevisiae. J Biol Chem. 269:1994;25295-25302.
31. Suzuki K.T., Karasawa A., Sunaga H., Kodama H., Yamanaka K. Uptake of copper from the blood-stream and its relation to induction of metallothionein synthesis in the rat. Compar Biochem Physiol. 94:1989;93-97.
32. Lin C.M., Kosman D.J. Copper uptake in wild type and copper metallothionein-deficient Saccharomyces cerevisiae. Kinetics and mechanism. J Biol Chem. 265:1990;9194-9200.
33. Dancis A., Yuan D.S., Haile D., Askwith D., Eide D., Moehle C., et al. Molecular characterization of a copper transport protein in S. cerevisiae: an unexpected role for copper in iron transport. Cell. 76:1994;393-402.
34. Dancis A., Haile D., Yuan D.S., Klausner R.D. The Saccharomyces cerevisiae transport protein (ctr1p). Biochemical characterization, regulation by copper, and physiological role in copper uptake. J Biol Chem. 269:1994;25660-25667.
35. Labbe S., Thiele D.J. Pipes and wiring: the regulation of copper uptake and distribution in yeast. Trends Microbiol. 7:1999;500-505.
36. Eide D.J. Molecular biology of metal ion transport in Saccharomyces cerevisiae. Annu Rev Nutr. 18:1998;441-469.
37. Zhou B., Gitschier J. hCTR1: a human gene for copper uptake identified by complementation in yeast. Proc Natl Acad Sci USA. 94:1997;7481-7486.
38. Lee J., Prohaska J.R., Dagenais S.L., Glover T.W., Thiele D.J. Isolation of a murine copper transporter gene, tissue specific expression and functional complementation of a yeast copper transport mutant. Gene. 254:2000;87-96.
39. Kuo Y- M., Zhou B., Cosco D., Gitschier J. The copper transporter CTR1 provides an essential function in mammalian embryonic development. Proc Natl Acad Sci USA. 98:2001;6836-6841.
40. Moller L.B., Petersen C., Lund C., Horn N. Characterization of the hCTR1 gene: genomic organization, function, expression and identification of a highly homologous processed gene. Gene. 257:2000;13-22.
41. Lee J., Prohaska J.R., Thiele D.J. Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development. Proc Natl Acad Sci USA. 98:2001;6842-6847.
42. Kampfenkel K., Kushnir S., Babiychuk E., Inze D., Van Montagu M. Molecular characterization of a putative Arabidopsis thaliana copper transporter and its yeast homologue. J Biol Chem. 270:1995;28479-28486.
43. Pena M.M.O., Lee J., Thiele D.J. A delicate balance: homeostatic control of copper uptake and distribution. J Nutr. 129:1999;1251-1260.
44. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 388:1997;482-488.
45. Liu X.F., Supek F., Nelson N., Culotta V.C. Negative control of heavy metal uptake by the Saccharomyces cerevisiae BSD2 gene. J Biol Chem. 272:1997;11763-11769.
46. Liu X.F., Culotta V.C. Post-translation control of Nramp metal transport in yeast. Role of metal ions and the BSD2 gene. J Biol Chem. 274:1999;4863-4868.
47. Fleming M.D., Trenor I.I.I.C.C., Su M.A., Foernsler D., Beier D.R., Dietrick W.F., et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet. 16:1997;383-386.
48. Fleming M.D., Romano M.A., Su M.A., Garrick L.M., Garrick M.D., Andrews N.C. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci USA. 95:1998;1148-1153.
49. Roy C.N., Enns C.A. Iron homeostasis: new tales from the crypt. Blood. 96:2000;4020-4027.
50. Andrews N.C. 2000 Intestinal iron absorption: current concepts circa. Dig Liver Dis. 32:2000;56-61.
51. Wirth P.L., Linder M.C. Distribution of copper among multiple components of human serum. J Natl Cancer Inst. 75:1985;277-284.
52. Barrow L., Tanner M.S. Copper distribution among serum proteins in paediatric liver disorder and malignancies. Eur J Clin Invest. 18:1988;555-560.
53. Linder M.C., Lomeli N.A., Donley S., Mehrbod F., Cerveza P., Cotton S., et al. Copper transport in mammals. Leone A., Mercer J.F.B. Copper transport and its disorders. 1999;1-16 Kluwer Academic/Plenum, New York.
54. Masuoka J., Hegenauer J., Van Dyke B.R., Saltman P. Intrinsic stoichiometric equilibrium constants for the binding of zinc(II) and copper(II) to the high affinity site of serum albumin. J Biol Chem. 268:1993;21533-21537.
55. Lau S., Sarkar B. Ternary coordination complex between human serum albumin, copper(II) and L-histidine. J Biol Chem. 246:1971;5938-5943.
56. Masuoka J., Saltman P. Zinc(II) and copper (II) binding to serum albumin. A comparative study of dog, bovine, and human albumin. J Biol Chem. 269:1994;25557-25561.
57. Weiss K.C., Linder M.C. Copper transport in rats involving a new plasma protein. Am J Physiol. 249:1985;E77-88.
58. Linder M.C., Wooten L., Cerveza P., Cotton S., Shulze R., Lomeli N. Copper transport. Am J Clin Nutr. 67:1998;965S-971S.
59. Goforth J., Vivas E., Liu N., Askary H.S., Lo L.S.L., Linder M.C. Correspondence between rat transcuprein and human alpha-2-macroglobulin in copper binding. FASEB J. 15:2001;. [Abstract A271].
60. Campbell C.H., Brown R., Linder M.C. Circulating ceruloplasmin is an important source of copper for normal and malignant cells. Biochim Biophys Acta. 678:1981;27-38.
61. Lee S.H., Lancey R., Montaser A., Madani N., Linder M.C. Ceruloplasmin and copper transport during the latter part of gestation in the rat. Proc Soc Exp Biol M. 203:1993;428-439.
62. Vargas E.J., Shoho A.R., Linder M.C. Copper transport in the Nagase analbuminemic rat. Am J Physiol. 267:1994;G259-269.
63. Orena S.J., Goode C.A., Linder M.C. Binding and uptake of copper from ceruloplasmin. Biochem Biophys Res Commun. 139:1986;822-825.
64. Harris Z.L., Takahashi Y., Miyajima H., Serizawa M., MacGillivray R.T.A., Gitlin J.D. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA. 92:1995;2539-2543.
65. Meyer L.A., Durley A.P., Prohaska J.R., Harris Z.L. Copper transport and metabolism are normal in Aceruloplasminemic mice. J Biol Chem. 276:2001;36857-36861.
66. Hilton M., Spenser D.C., Ross P., Ramsey A., McArdle H.J. Characterization of the copper uptake mechanism and isolation of the ceruloplasmin receptor/copper transporter in human placental vesicles. Biochim Biophys Acta. 1245:1995;153-160.
67. 67Cu by isolated human trophoblast cells. Biochim Biophys Acta. 1135:1992;123-128.
68. Percival S.S., Harris E.D. Copper transport from ceruloplasmin: characterization of the cellular uptake mechanism. Am J Physiol. 258:1990;C140-146.
69. Stevens M.D., DiSilvestro R.A., Harris E.D. Specific receptors for ceruloplasmin in membrane fragments from aortic and heart tissues. Biochemistry. 23:1984;261-266.
70. Kataoka M., Tavassoli M. Identification of ceruloplasmin receptors on the surface of human blood monocytes, granulocytes, and lymphocytes. Exp Hematol. 13:1985;806-810.
71. Tavassoli M., Kishimoto T., Kataoka M. Liver endothelium mediates the hepatocyte's uptake of ceruloplasmin. J Cell Biol. 102:1986;1298-1303.
72. Klomp L.W., Lin S.J., Yuan D.S., Klausner R.D., Culotta V.C., Gitlin J.D. Identification and functional expression of HAH1: a novel human gene involved in copper homeostasis. J Biol Chem. 272:1997;9221-9226.
73. Larin D., Mekios C., Das K., Ross B., Yang A.S., Gilliam T.C. Characterization of the interaction between the Wilson and Menkes disease proteins and the cytoplasmic chaperone, HAHI. J Biol Chem. 274:1999;28497-28504.
74. Culotta V.C., Klomp L.W., Strain J., Casareno R.L., Krems B., Gitlin J.D. The copper chaperone for superoxide dismutase. J Biol Chem. 272:1997;23469-23472.
75. Casareno R.L., Waggoner D., Gitlin J.D. The copper chaperone CCS directly interacts with copper/zinc superoxide dismutase. J Biol Chem. 273:1998;23625-23628.
76. Glerum D.M., Shtanko A., Tzagoloff A. Characterization of COX17: a yeast gene involved in copper metabolism and assembly of cytochrome oxidase. J Biol Chem. 271:1996;14504-14509.
77. Amaravadi R., Glerum D.M., Tzagoloff A. Isolation of a cDNA encoding the human homolog of COX17 a yeast gene essential for mitochondrial copper recruitment. Hum Genet. 99:1997;329-333.
78. Harris E.D. Cellular copper transport and metabolism. Annu Rev Nutr. 20:2000;291-310.
79. Portnoy M.E., Schmidt P.J., Rogers R.S., Culotta V.C. Metal transporters that contribute copper to metallochaperones in Saccharomyces cerevisiae. Mol Genet Genom. 265:2001;873-882.
80. Holmberg C.G., Laurell C.B. Investigations in serum copper. II. Isolation of the copper containing protein and a description of some of its properties. Acta Chem Scand. 2:1948;550-556.
81. Sato M., Gitlin J.D. Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin. J Biol Chem. 266:1991;5128-5134.
82. Miyajima H., Nishimura Y., Mizoguchi K., Sakamoto M., Shimizu T., Honda N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology. 37:1987;761-767.
83. Harris Z.L., Klomp L.W., Gitlin J.D. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am J Clin Nutr. 67:1998;972S-977S.
84. Paynter J.A., Gimes A., Lockhardt P., Mercer J.F. Expression of the Menkes gene homologue in mouse tissues lack of effect of copper on the mRNA levels. FEBS Lett. 351:1994;186-190.
85. Yamaguchi Y., Heiny M.E., Oitlin J.D. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun. 197:1993;271-277.
86. Petris M.J., Mercer J.F., Culvenor J.O., Lockhart P., Oleeson P.A., Camakaris J. Ligand-regulated transport of the Menkes copper P-type ATPase efflux pump from the golgi apparatus to the plasma membrane: a novel mechanism of regulated trafficking. EMBO J. 15:1996;6084-6095.
87. Hung I.H., Suzuki M., Yamaguchi Y., Yuan D.S., Klausner R.D., Oitlin J.D. Biochemical characterization of the Wilson disease protein and functional expression in the yeast Saccharomyces cerevisiae. J Biol Chem. 272:1997;21461-21466.
88. Schaefer M., Hopkins R.O., Failla M.L., Oitlin J.D. Hepatocyte-specific localization and copper-dependent trafficking of the Wilson's disease protein in the liver. Am J Physiol. 276:1999;G639-646.
89. Horn N. Copper incorporation studies on cultured cells for prenatal diagnosis of Menkes' disease. Lancet. 1:(1):1976;156-160.
90. Schilsky M.L. Identification of the Wilson's disease gene: clues for disease pathogenesis and the potential for molecular diagnosis. Hepatology. 20:1994;529-533.
91. Schilsky M.L., Stockert R.J., Sternlieb I. Pleiotropic effect of LEC mutation: a rodent model of Wilson's disease. Am J Physiol. 266:1994;G907-913.
92. Dijkstra M., van den Berg O.J., Wolters H., In't Veld O., Slooff M.J., Heymans H.S., et al. Adenosine triphosphate-dependent copper transport in human liver. J Hepatol. 25:1996;37-42.
93. Terada K., Aiba N., Yang X- L., Iida M., Nakai M., Miura N., et al. Biliary excretion of copper in LEC rat after introduction of copper transporting P-type ATPase, ATP7B. FEBS Lett. 448:1999;53-56.
94. Terada K., Nakako T., Yang X- L., Iida M., Aiba N., Minamiya Y., et al. Restoration of holoceruloplasmin synthesis in LEC rat after infusion of recombinant adenovirus bearing WND cDNA. J Biol Chem. 273:1998;1815-1820.
95. Tanzi R.E., Petrukhin K., Chernov I., Pellequer J.L., Wasco W., Ross B., et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet. 5:1993;344-350.
96. Nakamura K., Urakami K- I., Umeyama K., et al. Intracellular distribution of the Wilson's disease gene product (ATPase7B) after in vitro and in vivo exogenous expression in hepatocytes from the LEC rat: an animal model of Wilson's disease. Hepatology. 27:1998;799-807.
97. Dijkstra M., Vonk R.J., Kuipers F. How does copper get into bile? New insights into the mechanism(s) of hepatobiliary copper transport. J Hepatol. 24:1996;109-120.
98. Camakaris J., Voskoboinik I., Mercer J.F.B. Molecular mechanisms of copper homeostasis. Biochem Biophys Res Commun. 261:1999;225-232.
99. Schaefer M., Roelofsen J., Wolters H., Hofmann W.J., Muller M., Kuipers F., et al. Localization of the Wilson's disease protein in human liver. Gastroenterology. 117:1999;1380-1385.
100. Lutsenko S., Cooper M.J. Localization of the Wilson's disease protein product to mitochondria. Proc Natl Acad Sci USA. 95:1998;6004-6009.
101. Camakaris J., Petris M.J., Bailey L., Shen P., Lockhart P., Glover T.W., et al. Gene amplification of the Menkes (MNK ATP7 A) P-type ATPase gene of CHO cells is associated with copper resistance and enhanced copper efflux. Hum Mol Genet. 4:1995;2117-2123.
102. Petris M.J., Mercer J.F.B. The Menkes protein (ATP7A; MNK) cycles via the plasma membrane both in basal and elevated extracellular copper using a C-terminal di-leucine endocytic signal. Hum Mol Genet. 8:1999;2107-2115.
103. Roelofsen J., Wolters H., Van Luyn J.A., Miura N., Kuipers F., Vonk R.J. Copper-induced apical trafficking of ATP7B in polarized hepatoma cells provides a mechanism for biliary copper excretion. Gastroenterology. 119:2000;782-793.
104. Chowrimootoo G.F.E., Seymour C.A. The role of ceruloplasmin in copper excretion. Biochem Soc Trans. 22:1994;1905. [Abstract].
105. Rae T.D., Schmidt P.J., Pufahl R.A., Culotta V.C., O'Halloran T.V. Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science. 284:1999;805-808.
106. Warburg O. Über eisen, den sauerstoffübertragenden Bestandteil des Atrnungsfermentes. Biochem Z. 152:1924;479-494.
107. Ferguson-Miller S., Babcock G.T. Heme/copper terminal oxidases. Chem Rev. 96:1996;2889-2907.
108. Wikstrom M.K.F. Proton pump coupled to cytochrome-c oxidase in mitochondria. Nature. 266:1977;271-273.
109. Keilin D., Hartree E.F. Cytochrome a and cytochrome oxidase. Nature. 141:1938;870-871.
110. Linder M.C. Copper and genomic stability in mammals. Mutat Res. 475:2001;151-152.
111. Flood D.G., Reaume A.G., Gruner J.A., Hoffmann E.K., Hirsch J.D., Lin Y- G., et al. Hindlimb motor neurons require Cu/Zn superoxide dismutase for maintenance of neuromuscular junctions. Am J Pathol. 155:1999;663-672.
112. Valentine J.S., Hart P.J., Gralla E.B. Copper-zinc superoxide dismutase and ALS. Leone A., Mercer J.F.B. Copper transport and its disorders. 1999;193-203 Kluwer Academic/Plenum, New York.
113. Carri M.T., Battistoni A., Ferri A., Gabbianelli R., Rotilio G. A study of the dual role of copper in superoxide dismutase as antioxidant and pro-oxidant in cellular models of amyotropic lateral sclerosis. Leone A., Mercer J.F.B. Copper transport and its disorders. 1999;205-213 Kluwer Academic/Plenum, New York.
114. Johnson M.A., Macdonald T.L., Mannick J.B., Conaway M.R., Gaston B. Accelarated S-nitrosothiol breakdown by amyotropic lateral sclerosis mutant copper, zinc-superoxide dismutase. J Biol Chem. 276:2001;39872-39878.
115. Levy M.A., Tsai Y.H., Reaume A., Bray T.M. Cellular response of antioxidant metalloproteins in Cu/Zn SOD transgenic mice exposed to hyperoxia. Am J Physiol. 281:2001;L172-182.
116. Kang Y.J. The antioxidant function of metallothionein in the heart. Proc Soc Exp Biol M. 222:1999;263-273.
117. Ghoshal K., Majumder S., Li Z., Bray T.M., Jacob S.T. Transcriptional induction of MT-I and II genes in the livers of Cu/Zn-SOD knockout mice. Biochem Biophys Res Commun. 264:1999;735-742.
118. Ragan H.A., Nacht S., Lee G.R., Bishop C.R., Cartwright G.E. Effect of ceruloplasmin on plasma iron in copper deficient swine. Am J Physiol. 217:1969;1320-1323.
119. Osaki S., Johnson D.A. Mobilization of liver iron by ferroxidase (ceruloplasmin). J Biol Chem. 244:1969;5757-5761.
120. Harris Z.L., Durley A.P., Man T.M., Gitlin J.D. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci USA. 96:1999;10812-10817.
121. Yoshida K., Furihata K., Takeda S., Nakamura A., Yamamoto K., Hiyamuta S., et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet. 9:1995;267-272.
122. Roeser H.P., Lee G.R., Nacht S., Cartwright G.E. A role of ceruloplasmin in iron metabolism. J Clin Invest. 49:1980;2408-2417.
123. Patel B.N., David S. A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J Biol Chem. 272:1997;20185-20190.
124. Salzer J.L., Lovejoy L., Linder M.C., Rosen C. Ran-2, a glial lineage marker, is a GPI-anchored form of ceruloplasmin. J Neurosci. 54:1998;147-157.
125. Patel B.N., Dunn R.J., David S. Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J Biol Chem. 275:2000;4305-4310.
126. Harris Z.L., Klomp L.W., Gitlin J.D. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am J Clin Nutr. 67:1998;972S-977S.
127. 2 cell intestinal model. J Nutr Biochem. 13:2001;138-148.
128. Mukhopadhyay C.K., Mazumder B., Fox P.L. Role of hypoxia inducible factor-1 in transcription activation of ceruloplasmin by iron deficiency. J Biol Chem. 275:1999;21048-21054.
129. Vulpe C.D., Attieh Z.K., Allaeddine R.M., Su T. Identification of a ferroxidase activity for hephaestin. FASEB J. 15:2001;A800. [Abstract].
130. Fife R.S., Moody S., Houser D., Proctor C. Studies of copper transport in cultured bovine chondrocytes. Biochim Biophys Acta. 1201:1994;19-22.
131. Trackman P.C., Pratt A.M., Wolanski A., Tang S.S., Offner G.D., Troxler R.F., et al. Cloning of rat aorta lysyl oxidase cDNA: complete codons and predicted amino acid sequence. Biochemistry. 29:1990;4863-4870.
132. Hamalainen E.R., Jones T.A., Sheer D., Taskinen K., Pihlajaniemi T., Kivirikko K. Molecular cloning of human lysyl oxidase and assignment of the gene to chromosome 5q23.2-31. Genomics. 2:(11):1991;508-516.
133. Jourdan-Le Saux C., Tronecker H., Bogic L., Bryant-Greenwood G.D., Boyd C.D., Csiszar K. The LOXL2 gene encodes a new lysyl oxidase-like protein and is expressed at high levels in reproductive tissues. J Biol Chem. 274:1999;12939-12944.
134. Maki J.M., Kivirikko K. Cloning and characterization of a fourth human lysyl oxidase isoenzyme. Biochem J. 355:2001;381-387.
135. KIinman J.P. The catalytic function of bovine lysyl oxidase in the absence of copper. J Biol Chem. 276:2001;30575-30578.
136. Wang S.X., Mure M., Medzihradszky K.F., Burlingame A.L., Brown D.E., Dooley D.M., et al. A crosslinked cofactor in lysyl oxidase: redox function for amino acid side chains. Science. 273:1996;1078-1084.
137. Rucker R.B., Kosonen T., Clegg M.S., Mitchell A.E., Rucker B.R., Uriu-Hare J.Y., et al. Copper, lysyl oxidase, and extracellular matrix protein cross-linking. Am J Clin Nutr. 67:1998;996S-1002S.
138. Linder M.C., Donley S., Dominguez D., Wooten L., Mehrbod F., Cerveza P., et al. Copper transport and ceruloplasmin during lactation and pregnancy. Sarkar B. Metals and genetics. 1999;117-129 Kluwer Academic/Plenum, New York.
139. Muramatsu Y., Tamada T., Moralejo D.H., Suzuki Y., Matsumoto K. Fetal copper uptake and a homolog (Atp7b) of the Wilson's disease gene in rats. Res Commun Mol Pathol Pharmacol. 101:1998;225-231.
140. Oga M., Matsui N., Anai T., Yoshimatsu J., Inoue I., Miyakawa I. Copper disposition of the fetus and placenta in a patient with untreated Wilson's disease. Am J Obstet Gynecol. 169:1993;196-198.
141. 64Cu to foetal brindled (Mobr) mice. Biochem J. 186:1980;629-631.
142. Kuo Y- M., Gitschier J., Packman S. Developmental expression of the mouse mottled and toxic milk genes suggests distinct functions for the Menkes and Wilson disease copper transporters. Hum Mol Genet. 6:1997;1043-1049.
143. Coni E., Bocca B., Galoppi B., Alimonti A., Caroli S. Identification of chemical species of some trace and minor elements in mature breast milk. Microchem J. 67:2000;187-194.
144. Wooten L., Shulze R.A., Lancey R.W., Lietzow M., Linder M.C. Ceruloplasmin is found in milk and amniotic fluid and may have a nutritional role. J Nutr Biochem. 7:1996;632-639.
145. Olivares M., Pizarro F., Speisky H., Lonnerdal B., Uauy R. Copper in infant nutrition: safety of World Health Organization provisional guideline value for copper content of drinking water. J Pediat Gastroenterol Nutr. 26:1998;251-257.
146. Olivares M., Araya M., Uauy R. Copper homeostasis in infant nutrition: deficit and excess. J Pediatr Gastroenterol. 31:2000;102-111.
147. Chierici R., Saccomandi D., Vigi V. Dietary supplements for the lactating mother: influence on the trace element content of milk. Acta Paediatr. 88:1999;7-13.
148. Sethi S., Grover S., Khodaskar M.B. Role of copper in Indian childhood cirrhosis. Ann Trop Paediatr. 13:1993;3-5.
149. Muller T., Feichtinger H., Berger H., Muller W. Endemic Tyrolean infantile cirrhosis: an ecogenetic disorder. Lancet. 347:1996;877-880.
150. Purcell H., Mulcahy D. Circadian rhythms and the onset of myocardial infarction: clinical implications. J Cardiovasc Risk. 2:1995;510-514.
151. Vermeer S.E., Rinkel G.J., Algra A. Circadian fluctuations in onset of subarachnoid hemorrhage. New data on aneurysmal and perimesencephalic hemorrhage and a systematic review. Stroke. 28:1997;805-808.
152. Quigg M. Circadian rhythms: interactions with seizures and epilepsy. Epilepsy Res. 42:2000;43-55.
153. Arendt J. Melatonin and the mammalian pineal gland. 1995;Chapman & Hall, London.
154. Borjigin J., Li X., Snyder S.H. The pineal gland and melatonin: molecular and pharmacologic regulation. Annu Rev Pharmacol Toxicol. 39:1999;53-65.
155. Borjigin J., Payne A.S., Deng J., Li X., Wang M.M., Ovodenko B., et al. A novel pineal night-specific ATPase encoded by the Wilson disease gene. J Neurosci. 19:1999;1018-1026.
156. Bull P.C., Thomas G.R., Rommens J.M., Forbes J.R., Cox D.W. The Wilson disease gene is a putative copper transporting P-type A TPase similar to the Menkes gene. Nat Genet. 5:1993;327-337.
157. Tanzi R.E., Petrukhin K., Chernov I., Pellequer J.L., Wasco W., Toss B., et al. The Wilson disease gene is a copper-transporting ATPase with homology to the Menkes disease gene. Nat Genet. 5:1993;344-350.
158. Vulpe C., Levinson B., Whitney S., Packman S., Gitschier J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat Genet. 3:1993;7-13.
159. Wu J., Forbes J.R., Chen H.S., Cox D.W. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nat Genet. 7:1994;6541-6545.
160. Theophilos M.B., Cox D., Mercer J.F.B. The toxic milk mouse is a murine model of Wilson disease. Hum Mol Genet. 5:1996;1619-1624.
161. Okayasu T., Tochimaru H., Takahashi T., Takekoshi Y., Li Y., Togashi Y., et al. Inherited copper toxicity in Long-Evans Cinnamon rats exhibiting spontaneous hepatitis: a model of Wilson's disease. Pediatr Res. 31:1992;253-257.
162. Buiakova O.I., Xu J., Lutsenko S., Zeitlin S., Das K., Das S., et al. Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation. Hum Mol Genet. 9:1999;1665-1671.
163. Pufahl R.A., Singer C.P., Peariso K.L., Lin S.J., Schmidt P.J., Fahrni C.J., et al. Metal ion chaperone function of the soluble Cu(I) receptor Atxl. Science. 278:1997;853-856.
164. Olerum D.M., Shtanko A., Tzagoloff A. SCO1 and SCO2 act as high copy suppressors of a mitochondrial copper recruitment defect in Saccharomyces cerevisiae. J Biol Chem. 271:1996;20531-20535.
165. Srinivasan C., Posewitz M.C., George O.N., Winge D.R. Characterization of the copper chaperone Cox17 of Saccharomyces cerevisiae. Biochemistry. 37:1998;7572-7577.
166. Danks D.M., Cartwright E., Stevens B.J., Townley R.R. Menkes' kinky hair disease: further definition of the defect in copper transport. Science. 179:1973;1140-1142.
167. Danks D.M. Disorders of copper transport. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The metabolic basis of inherited disease. 1989;1411-1431 McGraw-Hill, New York.
168. Murata Y., Kodama H., Abe T., Ishida N., Nishimura M., Levinson B., et al. Mutation analysis and expression of the mottled gene in the macular mouse model of Menkes disease. Pediatr Res. 42:1997;436-442.
169. Francis M.J., Jones E.E., Levy E.R., Ponnambalam S., Chelly J., Monaco A.P. A golgi localization signal identified in the Menkes recombinant protein. Hum Mol Genet. 7:1998;1245-1252.
170. Petris M.J., Camakaris J., Greenough M., LaFontaine S., Mercer J.F.B. A C-terminal di-leucine is required for localization of the Menkes protein in the trans-golgi network. Hum Mol Genet. 7:1998;2063-2071.
171. Gitlin J.D. Aceruloplasminemia. Pediatr Res. 44:1998;271-276.
172. Roeser H.P., Lee G.R., Nacht S., Cartwright G.E. A role of ceruloplasmin in iron metabolism. J Clin Invest. 49:1980;2408-2417.
173. Strausak D., Mercer J.F., Dieter H.H., Stremmel W., Multhaup G. Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases. Brain Res Bull. 55:2001;175-185.
174. Cherny R.A., Atwood C.S.A., Xilinas M.E., Gray D.N., Jones W.D., McLean C.A., et al. Treatment with a copper-zinc chelator inhibits ß-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron. 30:2001;665-676.
175. Suzuki K., Miura T., Takeuchi H. Inhibitory effect of copper(II) on zinc(II)-induced aggregation of amyloid β-peptide. Biochem Biophys Res Commun. 285:2001;991-996.
176. Prusiner S.B. Molecular biology of prion diseases. Science. 252:1991;1515-1522.
177. Brown D.R., Clive C., Haswell S.J. Antioxidant activity related to copper binding of native prion protein. J Neurochem. 76:2001;69-76.
178. Brown D.R., Wong B- S., Hafiz F., Clive C., Haswell S.J., Jones I.M. Normal prion protein has an activity like that of superoxide dismutase. Biochem J. 344:1999;1-5.
179. Brown D.R., Hafiz F., Glasssmith L.L., Wong B- S., Jones I.M., Clive C., et al. Consequences of manganese replacement of copper for prion protein function and proteinase resistance. EMBO J. 19:2000;1180-1186.
180. 2+-binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. Biochemistry. 39:2000;12760-13771.
181. Miura T., Hori-l A., Takeuchi H. Raman spectroscopy study on the copper(II) binding mode of prion, octapeptide and its pH dependence. FEBS Lett. 396:1996;248-252.
182. McMahon H.E.M., Mange A., Nishida N., Cerminon C., Casanova D., Lehmann S. Cleavage of the amino terminus of the prion protein by reactive oxygen species. J Biol Chem. 276:2001;2286-2290.
183. Brown D.R. Prion or prejudice: normal protein and the synapse. Trends Neurosci. 24:2001;85-90.
184. Hornshaw M.P., McDermott J.R., Candy J.M. Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem Biophys Res Commun. 207:1995;621-629.
185. Prince R.C., Gunson D.E. Prions are copper-binding proteins. Trends Biochem Sci. 23:1998;197-198.
186. Viles J.H., Cohen F.E., Prusiner S.B., Goodin D.B., Wright P.E., Dyson H.J. Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc Natl Acad Sci USA. 96:1999;2042-2047.
187. Shyng S.L., Huber M.T., Harris D.A. A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J Biol Chem. 268:1993;15922-15928.
188. Pauly P.C., Harris D.A. Copper stimulates endocytosis of the prion protein. J Biol Chem. 273:1998;33107-33110.
189. McKenzie D., Bartz J., Mirwald J., Olander D., Marsh R., Aiken J. Reversibility of scrapie inactivation is enhanced by copper. J Biol Chem. 273:1998;25545-25547.
190. Milhavet O., McMahon H.E.M., Rachidi W., Nishida N., Katamine S., Mange A., et al. Prion infection impairs the cellular response to oxidative stress. Proc Natl Acad Sci USA. 97:2000;13937-13942.
191. Brown D.R. Prion protein expression aids cellular uptake and veratidine-induced release of copper. J Neurosci Res. 58:1999;717-725.
192. Brown D.R., Schmidt B., Kretzschmar H.A. Expression of prion protein in PC12 is enhanced by exposure to oxidative stress. Int J Dev Neurosci. 15:1997;961-972.
193. Sumudhu W., Perera S., Hooper N.M. Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat. Curr Biol. 11:2000;519-523.
194. Brockes J.P. Topics in prion cell biology. Curr Opin Neurobiol. 9:1999;571-577.
195. Hopkins R.G., Failla M.L. Transcriptional regulation of interleukin-2 gene expression is impaired by copper deficiency in Jurkat human T lymphocytes. J Nutr. 129:1999;596-601.
196. Percival S.S. Copper and immunity. Am J Clin Nutr. 67:1998;1064S-1068S.
197. Huang Z.L., Failla M.L. Copper deficiency suppresses effector activities of differentiated U937 cells. J Nutr. 130:2000;1536-1542.
198. Linder M.C., Moor J.R., Wright K. Ceruloplasmin assays in diagnosis and treatment of human lung, breast and gastrointestinal cancer. J Natl Cancer Inst. 67:1981;263-275.
199. Gullino P.M., Ziche M., Alessandri G. Ganglioside, copper ions and angiogenic capacity of adult tissues. Cancer Metastasis Rev. 8:1990;239-251.
200. Yoshida D., Ikeda Y., Nakazawa S. Copper chelation inhibits tumor angiogenesis in the experimental gliosarcoma model. Neurosurgery. 37:1995;287-292.
201. Brewer G.J. Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson's disease. Exp Biol M. 226:2001;665-667.
202. Tanner M.S. Indian childhood cirrhosis and Tyrolean childhood cirrhosis. Leone A., Mercer J.F.B. Copper transport and its disorders. 1999;127-137 Kluwer Academic, Plenum, New York.
203. Montaser A., Tetreault C., Linder M.C. Comparison of copper binding proteins in dog serum with those in other species. Proc Soc Exp Biol M. 200:1992;321-329.
204. Moore-Ede M.C., Sultzman F.M., Fuller C.A. The clocks that time us-physiology of the circadian timing system. 1982;Harvard University Press, Cambridge (MA.